- Home
- ARTW vs AYTU Comparison
ARTW vs AYTU Comparison
Compare ARTW & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- AYTU
- Stock Information
- Founded
- ARTW 1956
- AYTU N/A
- Country
- ARTW United States
- AYTU United States
- Employees
- ARTW N/A
- AYTU N/A
- Industry
- ARTW Industrial Machinery/Components
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- AYTU Health Care
- Exchange
- ARTW Nasdaq
- AYTU Nasdaq
- Market Cap
- ARTW 9.3M
- AYTU 9.6M
- IPO Year
- ARTW N/A
- AYTU N/A
- Fundamental
- Price
- ARTW $2.04
- AYTU $2.10
- Analyst Decision
- ARTW
- AYTU
- Analyst Count
- ARTW 0
- AYTU 0
- Target Price
- ARTW N/A
- AYTU N/A
- AVG Volume (30 Days)
- ARTW 14.4K
- AYTU 621.9K
- Earning Date
- ARTW 07-07-2025
- AYTU 05-14-2025
- Dividend Yield
- ARTW N/A
- AYTU N/A
- EPS Growth
- ARTW N/A
- AYTU N/A
- EPS
- ARTW 0.14
- AYTU N/A
- Revenue
- ARTW $23,916,932.00
- AYTU $81,659,000.00
- Revenue This Year
- ARTW N/A
- AYTU N/A
- Revenue Next Year
- ARTW N/A
- AYTU $8.68
- P/E Ratio
- ARTW $40.12
- AYTU N/A
- Revenue Growth
- ARTW N/A
- AYTU 0.41
- 52 Week Low
- ARTW $1.40
- AYTU $0.95
- 52 Week High
- ARTW $4.15
- AYTU $2.96
- Technical
- Relative Strength Index (RSI)
- ARTW 59.35
- AYTU 60.77
- Support Level
- ARTW $1.73
- AYTU $1.97
- Resistance Level
- ARTW $2.00
- AYTU $2.17
- Average True Range (ATR)
- ARTW 0.12
- AYTU 0.14
- MACD
- ARTW 0.01
- AYTU 0.00
- Stochastic Oscillator
- ARTW 94.07
- AYTU 58.33
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.